» Authors » Katalin A Wilkinson

Katalin A Wilkinson

Explore the profile of Katalin A Wilkinson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 120
Citations 5261
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Magodoro I, Guerrero-Chalela C, Carkeek E, Asafu-Agyei N, Jele N, Frigati L, et al.
Open Heart . 2024 Nov; 11(2). PMID: 39542524
Background: Whether, and how, co-occurring HIV-1 infection (HIV) and tuberculosis (TB) impact cardiovascular status, especially in adolescents with perinatally acquired HIV (APHIV), have not been examined. We hypothesised that APHIV...
2.
Walker N, Schutz C, Ward A, Barr D, Opondo C, Shey M, et al.
J Infect Dis . 2024 Sep; 231(1):109-114. PMID: 39219411
Mortality from human immunodeficiency virus (HIV)-associated tuberculosis (TB) is high, particularly among hospitalized patients. In 433 people with HIV hospitalized with symptoms of TB, we investigated plasma matrix metalloproteinases (MMP)...
3.
Pinna A, Ragaisyte I, Morton W, Angioletti-Uberti S, Proust A, DAntuono R, et al.
ACS Appl Mater Interfaces . 2024 Jul; 16(29):37623-37640. PMID: 38988046
Conditions affecting the brain are the second leading cause of death globally. One of the main challenges for drugs targeting brain diseases is passing the blood-brain barrier (BBB). Here, the...
4.
Magodoro I, Guerrero-Chalela C, Myer L, Jao J, Ntsekhe M, Wilkinson K, et al.
medRxiv . 2024 Apr; PMID: 38559174
Whether, and how, co-occurring HIV-1 infection (HIV) and tuberculosis (TB) impact cardiovascular status, especially in adolescents with perinatally acquired HIV (APHIV), have not been examined. We hypothesized that APHIV with...
5.
Booysen P, Wilkinson K, Sheerin D, Waters R, Coussens A, Wilkinson R
Front Immunol . 2023 Oct; 14:1254206. PMID: 37841282
SARS-CoV-2 and () are major infectious causes of death, with meta-analyses and population-based studies finding increased mortality in co-infected patients simultaneously diagnosed with COVID-19 and tuberculosis (TB). There is a...
6.
Gonzalez-Rodriguez E, Zol-Hanlon M, Bineva-Todd G, Marchesi A, Skehel M, Mahoney K, et al.
ACS Cent Sci . 2023 Mar; 9(3):393-404. PMID: 36968546
The emergence of a polybasic cleavage motif for the protease furin in SARS-CoV-2 spike has been established as a major factor for human viral transmission. The region N-terminal to that...
7.
du Bruyn E, Stek C, Daroowala R, Said-Hartley Q, Hsiao M, Schafer G, et al.
Nat Commun . 2023 Jan; 14(1):188. PMID: 36635274
Few studies from Africa have described the clinical impact of co-infections on SARS-CoV-2 infection. Here, we investigate the presentation and outcome of SARS-CoV-2 infection in an African setting of high...
8.
Fendler A, Shepherd S, Au L, Wu M, Harvey R, Wilkinson K, et al.
Cell Rep Med . 2022 Oct; 3(10):100781. PMID: 36240755
Patients with blood cancer continue to have a greater risk of inadequate immune responses following three COVID-19 vaccine doses and risk of severe COVID-19 disease. In the context of the...
9.
du Bruyn E, Fukutani K, Rockwood N, Schutz C, Meintjes G, Arriaga M, et al.
Lancet Microbe . 2022 May; 2(8):e375-e385. PMID: 35544195
Background: HIV-1 mediated dysregulation of the immune response to tuberculosis and its effect on the response to antitubercular therapy (ATT) is incompletely understood. We aimed to analyse the inflammatory profile...
10.
Fendler A, Shepherd S, Au L, Wilkinson K, Wu M, Schmitt A, et al.
Cancer Cell . 2022 Apr; 40(4):438. PMID: 35413273
No abstract available.